PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1108399
PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1108399
Global Liquid Biopsy Market, By Sampling Type, By Product and Service, By Circulating Biomarker, By Clinical Application, By Application, By End User, By Region Trend Analysis, Competitive Market Share & Forecast, 2018-2028
Global Liquid Biopsy Market to Grow at a CAGR of 19.7% during 2018 - 2028
Global Liquid Biopsy Market is flourishing owing to the rising demand for non-invasive technology that detects molecular biomarkers using liquid samples instead of expensive or invasive procedures along with the advantages of liquid biopsy such as ease of use and minimal invasiveness, early cancer diagnosis and detection, characterization of new lesions, and identification of the drug and therapeutic targets for cancer treatment…
A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Global Liquid Biopsy Market was worth USD 2.67 billion in the year 2021. The market is projected to grow at a CAGR of 19.7%, earning revenues of around USD 9.30 billion by the end of 2028. Global Liquid Biopsy Market is booming because of the expanding detection and isolation of circulating tumor DNA, exosomes, and circulating tumor cells. The rapid advancement of digital Polymerase Chain Reaction (PCR) and NGS-based technology has improved liquid biopsy accuracy. It can be used repeatedly to monitor disease progression and is expected to help overcome the limitations of tissue biopsies. Moreover, the constantly evolving pipeline of ctDNA-based liquid biopsy tests, an increasing number of commercialized products, and the potential of ctRNA in determining molecular profiles have all contributed to this segment's dominance. Furthermore, Global Liquid Biopsy Market is one of the most emerging markets that grow continuously owing to the fast integration of new technologies such as the Internet of Things (IoT), Artificial Intelligence (AI), cloud computing, and others. However, high costs associated with R&D capabilities, limited infrastructural facilities, and lower sensitivity of certain liquid biopsies are expected to stymie market growth, in turn, may act as a huge restraining factor for the market growth.
Increasing technological progress
Surging demand for advanced diagnostic equipment, combined with an increase in the number of research laboratories in developing economies, is driving the market growth rate. Furthermore, the rising prevalence of blood cancer around the world is paving the way for market expansion. Moreover, rising R&D spending, particularly in developed and developing economies, will create more lucrative market growth opportunities for medical instruments and devices. The research and development capabilities of pharmaceutical and biopharmaceutical countries for the integration of advanced technologies in healthcare facilities are also boosting market growth rates. As a result, the Global Liquid Biopsy Market is predicted to develop at a significant rate during the forecast period (2022-2028).
Growing Advantages of Liquid Biopsy in the Healthcare Industry
In hospitals, clinics, pathology labs, and other healthcare and research facilities, liquid biopsy tests are conducted to comprehend the molecular elements of cancer. Liquid biopsy is a non-invasive method that uses liquid samples to discover molecular biomarkers without the use of pricy or intrusive procedures. Liquid biopsies provide some advantages that increase the safety and effectiveness of cancer therapy for patients, including their ease of use and low invasiveness, early cancer diagnosis and detection, characterization of new lesions, and discovery of drug & therapeutic targets. This results in offering lucrative opportunities for the Global Liquid Biopsy Market during the forecast period (2022-2028).
Challenge: Vague Reimbursement Situation
The procedure of paying for pricey molecular testing and the knowledge of the several specialists needed to interpret test results and create treatment programs are convoluted and uneven. This is particularly problematic with more expensive modern methods like liquid biopsy. The price of molecular testing services is frequently unknown to doctors, pathologists, and patients until they are paid or billed. Both patients and medical professionals find the confusion disturbing. Additionally, payers' biomarker coverage policies have complex organizational structures that make them challenging to comprehend. While some only pay for the most fundamental tests or those related to certain clinical disorders and genes, others pay for a wide variety of testing. This wide range frequently makes assessing and tracking multiple coverage policies more difficult.
Segmental Coverage
Global Liquid Biopsy Market - By Circulating Biomarker
Based on circulating biomarkers, the Global Liquid Biopsy Market is segmented into Circulating Tumor Cells, Circulating Tumor DNA. The circulating tumor cells segment now has the biggest market share and is likely to continue to do so during the forecast period (2022-2028). This is due to the increased number of clinically important tests with genomic analyses in recent years. Furthermore, due to the rapid development of next-generation sequencing (NGS) technologies in liquid biopsy advancements applied to circulating tumor DNA, circulating tumor DNA is expected to be the fastest-growing segment during the forecast period (ctDNA).
Global Liquid Biopsy Market - By Clinical Application
Based on clinical application, the Global Liquid Biopsy Market is segmented into Early Cancer Screening, Therapy Selection, Treatment Monitoring, and Recurrence Monitoring. Among these, cancer screening dominates the market. While screening consists of evaluating healthy individuals to find those who have cancer before any symptoms occur, early diagnosis focuses on identifying symptomatic patients as early as feasible. Moreover, therapy selection is expected to dominate the market share. Therapy selection tests are a type of liquid biopsy in which substrates isolated from bodily fluids such as blood, saliva, or urine are sequenced. This method is less invasive, can be used more frequently, and is less expensive than tests involving tissue sampling via invasive procedures such as surgery.
Impact of COVID-19 on Global Liquid Biopsy Market
The coronavirus disease (COVID-19) has spread worldwide. As a result of the increased number of Coronavirus patients, governments have imposed several rules and lockdowns around the world, affecting the market growth in the early stages of the forecast period. As a result, early detection programs have been halted. Furthermore, there has been a decrease in cancer screenings, visits, therapies, and surgeries, with variations by cancer type and location of service globally, resulting in an increase in cancer morbidity and mortality in 2020. The pandemic has also had an impact on the logistics and supply of cancer diagnostic raw materials and components, as well as other critical commodities used in the production of liquid biopsy. During the COVID-19 pandemic, these factors limit the growth of the liquid biopsy market.
Competitive Landscape
The leading market players in the Global Liquid Biopsy Market are F. Hoffmann-La Roche Ltd, Myraid Genetics, QIAGEN, Thermo Fisher Scientific Inc, Guardant Health, MDxHealth SA, Exact Sciences Corporation, Sysmex Inostics, Bio-Rad Laboratories, ANGLE plc, and other prominent players. The Global Liquid Biopsy Market is highly fragmented with the presence of several manufacturing companies in the country. The market leaders retain their supremacy by spending on research and development, incorporating cutting-edge technology into their goods, and releasing upgraded items for customers. Various tactics, including strategic alliances, agreements, mergers, and partnerships, are used.
Don't miss the business opportunity in the Global Liquid Biopsy Market. Consult our analysts to gain crucial insights and facilitate your business growth.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Liquid Biopsy Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Liquid Biopsy Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Table of Contents
1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
2. Research Methodology
- 2.1. Qualitative Research
- 2.1.1. Primary & Secondary Research
- 2.2. Quantitative Research
- 2.3. Market Breakdown & Data Triangulation
- 2.3.1. Secondary Research
- 2.3.2. Primary Research
- 2.4. Breakdown of Primary Research Respondents, By Region
- 2.5. Assumption & Limitation
3. Executive Summary
4. Global Liquid Biopsy Market Insights
- 4.1. Industry Value Chain Analysis
- 4.2. DROC Analysis
- 4.2.1. Growth Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunities
- 4.2.4. Challenges
- 4.3. Technological Advancement/Recent Development
- 4.4. Regulatory Framework
- 4.5. Porter's Five Forces Analysis
- 4.5.1. Bargaining Power of Suppliers
- 4.5.2. Bargaining Power of Buyers
- 4.5.3. Threat of New Entrants
- 4.5.4. Threat of Substitutes
- 4.5.5. Intensity of Rivalry
5. Global Liquid Biopsy Market Overview
- 5.1. Market Size & Forecast by Value, 2018-2028
- 5.1.1. By Value (USD Million)
- 5.2. Market Share & Forecast
- 5.2.1. By Sampling Type
- 5.2.1.1. Blood Sampling
- 5.2.1.2. Urine Sampling
- 5.2.1.3. Saliva Sampling
- 5.2.1.4. Other Tissue Fluids Sampling
- 5.2.2. By Product and Service
- 5.2.2.1. Assay Kits
- 5.2.2.2. Instruments
- 5.2.2.3. Services
- 5.2.3. By Circulating Biomarker
- 5.2.3.1. Circulating Tumor Cells
- 5.2.3.2. Circulating Tumor DNA
- 5.2.4. By Clinical Application
- 5.2.4.1. Early Cancer Screening
- 5.2.4.2. Therapy Selection
- 5.2.4.3. Treatment Monitoring
- 5.2.4.4. Recurrence Monitoring
- 5.2.5. By Application
- 5.2.5.1. Cancer Applications
- 5.2.5.2. Non-Cancer Applications
- 5.2.6. By End User
- 5.2.6.1. Reference Laboratories
- 5.2.6.2. Hospitals
- 5.2.6.3. Physician Laboratories
- 5.2.6.4. Academic Researchers
- 5.2.6.5. Others
- 5.2.7. By Region
- 5.2.7.1. North America
- 5.2.7.2. Europe
- 5.2.7.3. The Asia Pacific
- 5.2.7.4. Latin America
- 5.2.7.5. The Middle East and Africa
- 5.2.1. By Sampling Type
6. North America Liquid Biopsy Market
- 6.1. Market Size & Forecast by Value, 2018-2028
- 6.1.1. By Value (USD Million)
- 6.2. Market Share & Forecast
- 6.2.1. By Sampling Type
- 6.2.2. By Product and Service
- 6.2.3. By Circulating Biomarker
- 6.2.4. By Application
- 6.2.5. By Clinical Application
- 6.2.6. By End User
- 6.2.7. By Country
- 6.2.7.1. United States
- 6.2.7.2. Canada
7. Europe Liquid Biopsy Market
- 7.1. Market Size & Forecast by Value, 2018-2028
- 7.1.1. By Value (USD Million)
- 7.2. Market Share & Forecast
- 7.2.1. By Sampling Type
- 7.2.2. By Product and Service
- 7.2.3. By Circulating Biomarker
- 7.2.4. By Application
- 7.2.5. By Clinical Application
- 7.2.6. By End User
- 7.2.7. By Country
- 7.2.7.1. Germany
- 7.2.7.2. United Kingdom
- 7.2.7.3. Italy
- 7.2.7.4. France
- 7.2.7.5. Spain
- 7.2.7.6. Rest of Europe
8. The Asia Pacific Liquid Biopsy Market
- 8.1. Market Size & Forecast by Value, 2018-2028
- 8.1.1. By Value (USD Million)
- 8.2. Market Share & Forecast
- 8.2.1. By Sampling Type
- 8.2.2. By Product and Service
- 8.2.3. By Circulating Biomarker
- 8.2.4. By Application
- 8.2.5. By Clinical Application
- 8.2.6. By End User
- 8.2.7. By Country
- 8.2.7.1. China
- 8.2.7.2. India
- 8.2.7.3. Japan
- 8.2.7.4. South Korea
- 8.2.7.5. Rest of Asia Pacific
9. Latin America Liquid Biopsy Market
- 9.1. Market Size & Forecast by Value, 2018-2028
- 9.1.1. By Value (USD Million)
- 9.2. Market Share & Forecast
- 9.2.1. By Sampling Type
- 9.2.2. By Product and Service
- 9.2.3. By Circulating Biomarker
- 9.2.4. By Application
- 9.2.5. By Clinical Application
- 9.2.6. By End User
- 9.2.7. By Country
- 9.2.7.1. Brazil
- 9.2.7.2. Mexico
- 9.2.7.3. Rest of Latin America
10. The Middle East & Africa Liquid Biopsy Market
- 10.1. Market Size & Forecast by Value, 2018-2028
- 10.1.1. By Value (USD Million)
- 10.2. Market Share & Forecast
- 10.2.1. By Sampling Type
- 10.2.2. By Product and Service
- 10.2.3. By Circulating Biomarker
- 10.2.4. By Application
- 10.2.5. By Clinical Application
- 10.2.6. By End User
- 10.2.7. By Country
- 10.2.7.1. Saudi Arabia
- 10.2.7.2. UAE
- 10.2.7.3. South Africa
- 10.2.7.4. Rest of Middle East & Africa
11. Competitive Landscape
- 11.1. List of Key Players and Their Offerings
- 11.2. Market Share Analysis, 2021
- 11.3. Competitive Benchmarking, By Operating Parameters
- 11.4. Key Strategic Development (Merger, Acquisition, Partnership, etc.)
12. Impact of Covid-19 on Global Liquid Biopsy Industry
13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
- 13.1. F. Hoffmann-La Roche Ltd
- 13.2. Myraid Genetics
- 13.3. QIAGEN
- 13.4. Thermo Fisher Scientific Inc
- 13.5. Guardant Health
- 13.6. MDxHealth SA
- 13.7. Exact Sciences Corporation
- 13.8. Sysmex Inostics
- 13.9. Bio-Rad Laboratories
- 13.10. ANGLE plc
- 13.11. Other Prominent Players
14. Key Strategic Recommendations
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Figures
- Figure 1: Global Liquid Biopsy Market Segmentation
- Figure 2: Global Liquid Biopsy Industry Value Chain Analysis
- Figure 3: Global Liquid Biopsy Market Size, By Value (USD Million), 2018-2028
- Figure 4: Global Liquid Biopsy Market Share (%), By Sampling Type, By Value, 2018-2028
- Figure 5: Global Liquid Biopsy Market Share (%), By Product and Service, By Value, 2018-2028
- Figure 6: Global Liquid Biopsy Market Share (%), By Circulating Biomarker, By Value, 2018-2028
- Figure 7: Global Liquid Biopsy Market Share (%), By Application, By Value, 2018-2028
- Figure 8: Global Liquid Biopsy Market Share (%), By Clinical Application, By Value, 2018-2028
- Figure 9: Global Liquid Biopsy Market Share (%), By End User, By Value, 2018-2028
- Figure 10: Global Liquid Biopsy Market Share (%), By Country, By Value, 2018-2028
- Figure 11: North America Liquid Biopsy Market Size, By Value (USD Million), 2018-2028
- Figure 12: North America Liquid Biopsy Market Share (%), By Sampling Type, By Value, 2018-2028
- Figure 13: North America Liquid Biopsy Market Share (%), By Product and Service, By Value, 2018-2028
- Figure 14: North America Liquid Biopsy Market Share (%), By Circulating Biomarker, By Value, 2018-2028
- Figure 15: North America Liquid Biopsy Market Share (%), By Application, By Value, 2018-2028
- Figure 16: North America Liquid Biopsy Market Share (%), By Clinical Application, By Value, 2018-2028
- Figure 17: North America Liquid Biopsy Market Share (%), By End User, By Value, 2018-2028
- Figure 18: North America Liquid Biopsy Market Share (%), By Country, By Value, 2018-2028
- Figure 19: Europe Liquid Biopsy Market Size, By Value (USD Million), 2018-2028
- Figure 20: Europe Liquid Biopsy Market Share (%), By Sampling Type, By Value, 2018-2028
- Figure 21: Europe Liquid Biopsy Market Share (%), By Product and Service, By Value, 2018-2028
- Figure 22: Europe Liquid Biopsy Market Share (%), By Circulating Biomarker, By Value, 2018-2028
- Figure 23: Europe Liquid Biopsy Market Share (%), By Application, By Value, 2018-2028
- Figure 24: Europe Liquid Biopsy Market Share (%), By Clinical Application, By Value, 2018-2028
- Figure 25: Europe Liquid Biopsy Market Share (%), By End User, By Value, 2018-2028
- Figure 26: Europe Liquid Biopsy Market Share (%), By Country, By Value, 2018-2028
- Figure 27: The Asia-Pacific Liquid Biopsy Market Size, By Value (USD Million), 2018-2028
- Figure 28: The Asia-Pacific Liquid Biopsy Market Share (%), By Sampling Type, By Value, 2018-2028
- Figure 29: Asia-Pacific Liquid Biopsy Market Share (%), By Product and Service, By Value, 2018-2028
- Figure 30: Asia-Pacific Liquid Biopsy Market Share (%), By Circulating Biomarker, By Value, 2018-2028
- Figure 31: The Asia-Pacific Liquid Biopsy Market Share (%), By Application, By Value, 2018-2028
- Figure 32: The Asia-Pacific Liquid Biopsy Market Share (%), By Clinical Application, By Value, 2018-2028
- Figure 33: The Asia-Pacific Liquid Biopsy Market Share (%), By End User, By Value, 2018-2028
- Figure 34: The Asia-Pacific Liquid Biopsy Market Share (%), By Country, By Value, 2018-2028
- Figure 35: Latin America Liquid Biopsy Market Size, By Value (USD Million), 2018-2028
- Figure 36: Latin America Liquid Biopsy Market Share (%), By Sampling Type, By Value, 2018-2028
- Figure 37: Europe Liquid Biopsy Market Share (%), By Product and Service, By Value, 2018-2028
- Figure 38: Europe Liquid Biopsy Market Share (%), By Circulating Biomarker, By Value, 2018-2028
- Figure 39: Latin America Liquid Biopsy Market Share (%), By Application, By Value, 2018-2028
- Figure 40: Latin America Liquid Biopsy Market Share (%), By Clinical Application, By Value, 2018-2028
- Figure 41: Latin America Liquid Biopsy Market Share (%), By End User, By Value, 2018-2028
- Figure 42: Latin America Liquid Biopsy Market Share (%), By Country, By Value, 2018-2028
- Figure 43: The Middle East & Africa Liquid Biopsy Market Size, By Value (USD Million), 2018-2028
- Figure 44: The Middle East & Africa Liquid Biopsy Market Share (%), By Sampling Type, By Value, 2018-2028
- Figure 45: The Middle East & Africa Liquid Biopsy Market Share (%), By Product and Service, By Value, 2018-2028
- Figure 46: The Middle East & Africa Liquid Biopsy Market Share (%), By Circulating Biomarker, By Value, 2018-2028
- Figure 47: The Middle East & Africa Liquid Biopsy Market Share (%), By Application, By Value, 2018-2028
- Figure 48: The Middle East & Africa Liquid Biopsy Market Share (%), By Clinical Application, By Value, 2018-2028
- Figure 49: The Middle East & Africa Liquid Biopsy Market Share (%), By End User, By Value, 2018-2028
- Figure 50: The Middle East & Africa Liquid Biopsy Market Share (%), By Country, By Value, 2018-2028
- Figure 51: Global Liquid Biopsy Market Share Analysis, 2021
List of Tables
- Table 1: Global Liquid Biopsy Market Size, By Sampling Type, By Value (USD Million), 2018-2028
- Table 2: Global Liquid Biopsy Market Size, By Product and Service, By Value (USD Million), 2018-2028
- Table 3: Global Liquid Biopsy Market Size, By Circulating Biomarker, By Value (USD Million), 2018-2028
- Table 4: Global Liquid Biopsy Market Size, By Application, By Value (USD Million), 2018-2028
- Table 5: Global Liquid Biopsy Market Size, By Clinical Application, By Value (USD Million), 2018-2028
- Table 6: Global Liquid Biopsy Market Size, By End User, By Value (USD Million), 2018-2028
- Table 7: Global Liquid Biopsy Market Size. By Country, By Value (USD Million), 2018-2028
- Table 8: North America Liquid Biopsy Market Size, By Sampling Type, By Value (USD Million), 2018-2028
- Table 9: North America Liquid Biopsy Market Size, By Product and Service, By Value (USD Million), 2018-2028
- Table 10: North America Liquid Biopsy Market Size, By Circulating Biomarker, By Value (USD Million), 2018-2028
- Table 11: 28 North America Liquid Biopsy Market Size (USD Million), By Application, By Value 2018-2028
- Table 12: North America Liquid Biopsy Market Size, By Clinical Application, By Value (USD Million), 2018-2028
- Table 13: North America Liquid Biopsy Market Size, By End User, By Value (USD Million), 2018-2028
- Table 14: 28 North America Liquid Biopsy Market Size (USD Million), By Country, By Value 2018-2028
- Table 15: Europe Liquid Biopsy Market Size, By Sampling Type, By Value (USD Million), 2018-2028
- Table 16: Europe Liquid Biopsy Market Size, By Product and Service, By Value (USD Million), 2018-2028
- Table 17: Europe Liquid Biopsy Market Size, By Circulating Biomarker, By Value (USD Million), 2018-2028
- Table 18: 40 Europe Liquid Biopsy Market Size (USD Million), By Application, By Value 2018-2028
- Table 19: Europe Liquid Biopsy Market Size, By Clinical Application, By Value (USD Million), 2018-2028
- Table 20: Europe Liquid Biopsy Market Size, By End User, By Value (USD Million), 2018-2028
- Table 21: 40 Europe Liquid Biopsy Market Size (USD Million), By Country, By Value 2018-2028
- Table 22: The Asia-Pacific Liquid Biopsy Market Size, By Sampling Type, By Value (USD Million), 2018-2028
- Table 23: The Asia-Pacific Liquid Biopsy Market Size, By Product and Service, By Value (USD Million), 2018-2028
- Table 24: The Asia-Pacific Liquid Biopsy Market Size, By Circulating Biomarker, By Value (USD Million), 2018-2028
- Table 25: The Asia-Pacific Liquid Biopsy Market Size (USD Million), By Application, By Value 2018-2028
- Table 26: The Asia-Pacific Liquid Biopsy Market Size, By Clinical Application, By Value (USD Million), 2018-2028
- Table 27: The Asia-Pacific Liquid Biopsy Market Size, By End User, By Value (USD Million), 2018-2028
- Table 28: The Asia-Pacific Liquid Biopsy Market Size (USD Million), By Country, By Value 2018-2028
- Table 29: Latin America Liquid Biopsy Market Size, By Sampling Type, By Value (USD Million), 2018-2028
- Table 30: Latin America Liquid Biopsy Market Size, By Product and Service, By Value (USD Million), 2018-2028
- Table 31: Latin America Liquid Biopsy Market Size, By Circulating Biomarker, By Value (USD Million), 2018-2028
- Table 32: Latin America Liquid Biopsy Market Size (USD Million), By Application, By Value 2018-2028
- Table 33: Latin America Liquid Biopsy Market Size, By Clinical Application, By Value (USD Million), 2018-2028
- Table 34: Latin America Liquid Biopsy Market Size, By End User, By Value (USD Million), 2018-2028
- Table 35: Latin America Liquid Biopsy Market Size (USD Million), By Country, By Value 2018-2028
- Table 36: The Middle East & Africa Liquid Biopsy Market Size, By Sampling Type, By Value (USD Million), 2018-2028
- Table 37: The Middle East & Africa Liquid Biopsy Market Size, By Product and Service, By Value (USD Million), 2018-2028
- Table 38: The Middle East & Africa Liquid Biopsy Market Size (USD Million), By Circulating Biomarker, By Value 2018-2028
- Table 39: The Middle East & Africa Liquid Biopsy Market Size (USD Million), By Application, By Value 2018-2028
- Table 40: The Middle East & Africa Liquid Biopsy Market Size, By Clinical Application, By Value (USD Million), 2018-2028
- Table 41: The Middle East & Africa Liquid Biopsy Market Size, By End User, By Value (USD Million), 2018-2028
- Table 42: The Middle East & Africa Liquid Biopsy Market Size (USD Million), By Country, By Value 2018-2028
- Table 43: List of Key Players and Their Offerings
- Table 44: Competitive Benchmarking, by Operating Parameters
- Table 45 F. Hoffmann-La Roche Ltd Company Overview
- Table 46 F. Hoffmann-La Roche Ltd Financial Overview
- Table 47 Myraid Genetics Company Overview
- Table 48 Myraid Genetics Financial Overview
- Table 49 QIAGEN Company Overview
- Table 50 QIAGEN Financial Overview
- Table 51 Thermo Fisher Scientific Inc Company Overview
- Table 52 Thermo Fisher Scientific Inc Financial Overview
- Table 53 Guardant Health Company Overview
- Table 54 Guardant Health Financial Overview
- Table 55 MDxHealth SA Company Overview
- Table 56 MDxHealth SA Financial Overview
- Table 57 Exact Sciences Corporation Company Overview
- Table 58 Exact Sciences Corporation Financial Overview
- Table 59 Sysmex Inostics Company Overview
- Table 60 Sysmex Inostics Financial Overview
- Table 61 Bio-Rad Laboratories Company Overview
- Table 62 Bio-Rad Laboratories Financial Overview
- Table 63 ANGLE plc Company Overview
- Table 64 ANGLE plc Financial Overview
